DE

Deborah A. Eppstein

S( Syntex (U.S.A.): 14 patents #27 of 599Top 5%
Overall (All Time): #255,479 of 4,157,543Top 7%
18
Patents All Time

Issued Patents All Time

Patent #TitleCo-InventorsDate
10351823 Methods and compositions for expanding, identifying, characterizing and enhancing potency of mammalian-derived glial restricted progenitor cells Robert Sandrock, James T. Campanelli 2019-07-16
6387395 N-[1, (1-1) -dialkyloxy] - and N- [1, (1-1) -dialkenyloxy]- alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor Philip Felgner, Thomas Gadek, Gordon H. Jones, Richard B. Roman 2002-05-14
5783179 C-reactive protein fragment with immunomodulatory activity John J. Nestor, Teresa H. Ho, Philip Felgner, Barbara P. Barna, Sharad D. Deodhar 1998-07-21
5622712 N-[.omega., (.omega.-1)-dialkyloxy]- and N-[.omega., (.omega.-1)-dialkenyloxy]-alk-1-yl-N, N, N-tetrasubstituted ammonium lipids and uses therefor Philip Felgner, Thomas Gadek, Gordon H. Jones, Richard B. Roman 1997-04-22
5550289 N-(1,(1-1)-dialkyloxy)-and N-(1,(1-1)-dialkenyloxy alk-1-yl-N-N,N-tetrasubstituted ammonium lipids and uses therefor Philip Felgner, Thomas Gadek, Gordon H. Jones, Richard B. Roman 1996-08-27
5545412 N-[1, (1-1)-dialkyloxy]-and N-[1, (1-1)-dialkenyloxy]-alk-1-yl-n,n,n-tetrasubstituted ammonium lipids and uses therefor Philip Felgner, Thomas Gadek, Gordon H. Jones, Richard B. Roman 1996-08-13
5458140 Enhancement of transdermal monitoring applications with ultrasound and chemical enhancers Jonathan A. Eppstein, Joseph Kost, Robert S. Langer 1995-10-17
5445611 Enhancement of transdermal delivery with ultrasound and chemical enhancers Jonathan A. Eppstein 1995-08-29
5366737 N-[.omega.,(.omega.-1)-dialkyloxy]- and N-[.omega.,(.omega.-1)-dialkenyloxy]-alk-1-yl-N,N,N,-tetrasubstituted ammonium lipids and uses therefor Philip Felgner, Thomas Gadek, Gordon H. Jones, Richard B. Roman 1994-11-22
5208036 N-(.omega., (.omega.-1)-dialkyloxy)- and N-(.omega., (.omega.-1)-dialkenyloxy)-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor Philip Felgner, Thomas Gadek, Gordon H. Jones, Richard B. Roman 1993-05-04
5049386 N-.omega.,(.omega.-1)-dialkyloxy)- and N-(.omega.,(.omega.-1)-dialkenyloxy)Alk-1-YL-N,N,N-tetrasubstituted ammonium lipids and uses therefor Philip Felgner, Thomas Gadek, Gordon H. Jones, Richard B. Roman 1991-09-17
4962091 Controlled release of macromolecular polypeptides Brian Schryver 1990-10-09
4946787 N-(.omega.,(.omega.-1)-dialkyloxy)- and N-(.omega.,(.omega.-1)-dialkenyloxy)-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor Philip Felgner, Thomas Gadek, Gordon H. Jones, Richard B. Roman 1990-08-07
4897355 N[.omega.,(.omega.-1)-dialkyloxy]- and N-[.omega.,(.omega.-1)-dialkenyloxy]-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor Philip Felgner, Thomas Gadek, Gordon H. Jones, Richard B. Roman 1990-01-30
4857316 Synergistic antiviral composition 1989-08-15
4684625 Method for enhancing the anti-infective activity of muramyldipeptide derivatives Elizabeth Fraser-Smith, Thomas R. Matthews 1987-08-04
4606917 Synergistic antiviral composition 1986-08-19
4522811 Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides Elizabeth Fraser-Smith, Thomas R. Matthews 1985-06-11